The Scientific Basis for the Reputed Activity of Valerian
- 1 May 1999
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 51 (5) , 505-512
- https://doi.org/10.1211/0022357991772772
Abstract
The underground organs of members of the genus Valeriana (Valerianaceae), as well as related genera such as Nardostachys, are used in the traditional medicine of many cultures as mild sedatives and tranquillizers and to aid the induction of sleep. V. officinalis is the species most commonly used in northern Europe and still retains its official pharmaco-poeial status although it is most commonly encountered as an ingredient of herbal medicines. This plant is still the subject of considerable research aimed at establishing the chemical and pharmacological basis of the activity which has been clearly shown in a number of animal and clinical studies. The constituents of the volatile oil are very variable due to population differences in genetics and to environmental factors. The major constituents include the monoterpene bornyl acetate and the sesquiterpene valerenic acid, which is characteristic of the species, in addition to other types of sesquiterpene. Some of these have been shown to have a direct action on the amygdaloid body of the brain and valerenic acid has been shown to inhibit enzyme-induced breakdown of GABA in the brain resulting in sedation. The non-volatile monoterpenes known as valepotriates were first isolated in 1966 and contribute to the overall activity by possessing sedative activity based on the CNS although the mode of action is not clearly known. The valepotriates themselves act as prodrugs which are transformed into homobaldrinal which has been shown to reduce the spontaneous motility of mice. More recent studies have shown that aqueous extracts of the roots contain appreciable amounts of GABA which could directly cause sedation but there is some controversy surrounding the bioavailability of this compound. Another recent finding is the presence of a lignan, hydroxypinoresinol, and its ability to bind to benzodiazepine receptors. Valerian is a good example of both the negative and positive aspects of herbal drugs. The considerable variation in its composition and content as well as the instability of some of its constituents pose serious problems for standardization but the range of components which contribute to its overall activity suggest that it may correct a variety of underlying causes of conditions which necessitate a general sedative or tranquillizing effect.Keywords
This publication has 22 references indexed in Scilit:
- Cytotoxic potential of valerian constituents and valerian tincturesPhytomedicine, 1998
- Neuropharmacological Studies on Ethanol Extracts ofValeriana officinalisL.: Behavioural and Anticonvulsant PropertiesPhytotherapy Research, 1996
- An Aqueous Extract of Valerian Influences the Transport of GABA in SynaptosomesPlanta Medica, 1994
- Aqueous Extract of Valerian Reduces Latency to Fall Asleep in ManPlanta Medica, 1985
- Central Nervous Depressant Activity of Valerenic Acid in the MousePlanta Medica, 1985
- The Action of Valepotriates on the Synthesis of DNA and Proteins of Cultured Hepatoma CellsPlanta Medica, 1983
- Hemmung des γ-Aminobuttersäureabbaus durch ValerensäurederivatePlanta Medica, 1982
- Pharmacological Screening of Valerenal and some other Components of Essential Oil of Valeriana officinalisPlanta Medica, 1981
- Valepotriates, a New Class of Cytotoxic and Antitumor AgentsPlanta Medica, 1981
- Pharmacological Investigation of Certain Valeriana officinalis L. ExtractsJournal of Pharmaceutical Sciences, 1961